Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds

Journal of Virology

Volumn 78, Issue 20, 2004, Pages 11061-11069

  Zhang, Ying ^a   Simpson, Alan A ^a   Ledford, Rebecca M ^b   Bator, Carol M ^a   Chakravarty, Sugoto ^a,c   Skochko, Gregory A ^b   Demenczuk, Tina M ^b   Watanyar, Adiba ^b   Pevear, Daniel C ^b   Rossmann, Michael G ^a  

^a PURDUE UNIVERSITY   (United States)

^b ViroPharma Incorporated   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLECONARIL; RNA; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ADHESION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG BINDING; DRUG BINDING SITE; DRUG EFFECT; DRUG INHIBITION; HELA CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS 14; HUMAN RHINOVIRUS 16; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN STRUCTURE; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BINDING SITES; CRYSTALLIZATION; HELA CELLS; HUMANS; MODELS, MOLECULAR; OXADIAZOLES; RHINOVIRUS; VIRUS ASSEMBLY; VIRUS REPLICATION; X-RAY DIFFRACTION;

EID: 4644342919     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.20.11061-11069.2004     Document Type: Article

References (50)

1. Andries, K. 1995. Anti-picornaviral agents, p. 287-319. In D. J. Jeffries and E. DeCelercq (ed.), Antiviral chemotherapy. John Wiley and Sons, New York, N.Y.
2. Arnold, E., G. Vriend, M. Luo, J. P. Griffith, G. Kamer, J. W. Erickson, J. E. Johnson, and M. G. Rossmann. 1987. The structure determination of a common cold virus, human rhinovirus 14. Acta Crystallogr. Sect. A 43:346-361.
3. Badger, J., I. Minor, M. J. Kremer, M. A. Oliveira, T. J. Smith, J. P. Griffith, D. M. A. Guerin, S. Krishnaswamy, M. Luo, M. G. Rossmann, M. A. McKinlay, G. D. Diana, F. J. Dutko, M. Fancher, R. R. Rueckert, and B. A. Heinz. 1988. Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc. Natl. Acad. Sci. USA 85:3304-3308.
4. Bolotovsky, R., I. Steller, and M. G. Rossmann. 1998. The use of partial reflections for scaling and averaging X-ray area-detector data. J. Appl. Crystallogr. 31:708-717.
5. Brünger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. Sect. D 54:905-921.
6. Chapman, M. S., I. Minor, M. G. Rossmann, G. D. Diana, and K. Andries. 1991. Human rhinovirus 14 complexed with antiviral compound R 61837. J. Mol. Biol. 217:455-463.
7. Diana, G. D., P. Rudewicz, D. C. Pevear, T. J. Nitz, S. C. Aldous, D. J. Aldous, D. T. Robinson, T. Draper, F. J. Dutko, C. Aldi, G. Gendron, R. C. Oglesby, D. L. Volkots, M. Reuman, T. R. Bailey, R. Czerniak, T. Block, R. Roland, and J. Oppermann. 1995. Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism. J. Med. Chem. 38:1355-1371.
8. Ding, J., A. D. Smith, S. C. Geisler, X. Ma, G. F. Arnold, and E. Arnold. 2002. Crystal structure of a human rhinovirus that displays part of the HIV-1 V3 loop and induces neutralizing antibodies against HIV-1. Structure 10:999-1011.
9. Esnouf, R. M. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15: 132-134.
10. Filman, D. J., R. Syed, M. Chow, A. J. Macadam, P. D. Minor, and J. M. Hogle. 1989. Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8:1567-1579.
11. Fox, M. P., M. A. McKinlay, G. D. Diana, and F. J. Dutko. 1991. Binding affinities of structurally related human rhinovirus capsid-binding compounds are correlated to their activities against human rhinovirus type 14. Antimicrob. Agents Chemother. 35:1040-1047.
12. Fox, M. P., M. J. Otto, and M. A. McKinlay. 1986. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug. Antimicrob. Agents Chemother. 30:110-116.
13. Grant, R. A., C. N. Hiremath, D. J. Filman, R. Syed, K. Andries, and J. M. Hogle. 1994. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr. Biol. 4:784-797.
14. Hadfield, A. T., G. D. Diana, and M. G. Rossmann. 1999. Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16. Proc. Natl. Acad. Sci. USA 96:14730-14735.
15. Hadfield, A. T., M. A. Oliveira, K. H. Kim, I. Minor, M. J. Kremer, B. A. Heinz, D. Shepard, D. C. Pevear, R. R. Rueckert, and M. G. Rossmann. 1995. Structural studies on human rhinovirus 14 drug-resistant compensation mutants. J. Mol. Biol. 253:61-73.
16. Haydeo, F. G., D. T. Herrington, T. L. Coats, K. H. Kim, E. C. Cooper, S. A. Villano, S. Liu, S. Hudson, D. C. Pevear, M. Collett, and M. A. McKinlay. 2003. Efficacy and safety of oral pleconaril for treatment of picornavirus colds in adults: results of two double-blind, randomized, placebo-controlled trials. Clin. Infect. Dis. 36:1523-1532.
17. Heinz, B. A., R. R. Rueckert, D. A. Shepard, F. J. Dutko, M. A. McKinlay, M. Fancher, M. G. Rossmann, J. Badger, and T. J. Smith. 1989. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63:2476-2485.
18. Hendry, E., H. Hatanaka, E. Fry, M. Smyth, J. Tate, G. Stanway, J. Santti, M. Maaronen, T. Hyypiä, and D. Stuart. 1999. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7:1527-1538.
19. Hiremath, C. N. 1995. Binding of antiviral drug WIN51711 to the Sabin strain of type 3 poliovirus: structural comparison with drug binding in rhinovirus 14. Acta Crystallogr. Sect. D 51:473-489.
20. Kim, K. H., P. Willingmann, Z. X. Gong, M. J. Kremer, M. S. Chapman, I. Minor, M. A. Oliveira, M. G. Rossmann, K. Andries, G. D. Diana, F. J. Dutko, M. A. McKinlay, and D. C. Pevear. 1993. A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. J. Mol. Biol. 230:206-226.
21. Kim, S., T. J. Smith, M. S. Chapman, M. G. Rossmann, D. C. Pevear, F. J. Dutko, P. J. Felock, G. D. Diana, and M. A. McKinlay. 1989. Crystal structure of human rhinovirus serotype 1A (HRV1A). J. Mol. Biol. 210:91-111.
22. King, A. M. Q., F. Brown, P. Christian, T. Hovi, T. Hyypiä, N. J. Knowles, S. M. Lemon, P. D. Minor, A. C. Palmenberg, T. Skern, and G. Stanway. 2000. Family Picornaviridae, p. 657-678. In M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carsten, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle, and R. B. Wickner (ed.), Virus taxonomy. Academic Press, San Diego, Calif.
23. Kleywegt, G. J. 1995. Dictionaries for heteros. CCP4/ESF-EACBM Newsl. Protein Crystallogr. 31:45-50.
24. Kolatkar, P. R., J. Bella, N. H. Olson, C. M. Bator, T. S. Baker, and M. G. Rossmann. 1999. Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor. EMBO J. 18:6249-6259.
25. Kraulis, P. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946-950.
26. Ledford, R. M., N. R. Patel, T. M. Demenczuk, A. Watanyar, T. Herbertz, M. Collett, and D. C. Pevear. 2004. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds. J. Virol. 78:3663-3674.
27. Lentz, K. N., A. D. Smith, S. C. Geisler, S. Cox, P. Buontempo, A. Skelton, J. DeMartino, E. Rozhon, J. Schwartz, V. Girijavallabhan, J. O'Connell, and E. Arnold. 1997. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of the three poliovirus serotypes. Structure 5:961-978.
28. Lybrand, T. P. 1991. Molecular simulation and drug design. J. Pharm. Belg. 46:49-54.
29. McKinlay, M. A., F. J. Dutko, D. C. Pevear, M. G. Woods, G. D. Diana, and M. G. Rossmann. 1990. Rational design of antipicornavirus agents, p. 366-372. In M. A. Brinton and F. X. Heinz (ed.), New aspects of positive-strand RNA viruses. American Society for Microbiology, Washington, D.C.
30. Merritt, E. A., and D. J. Bacon. 1997. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277:505-524.
31. Mosser, A. G., and R. R. Rueckert. 1996. Capsid-binding agents, p. 13-40. In D. D. Richman (ed.), Antiviral drug resistance. John Wiley and Sons, Inc., Chichester, England.
32. Mosser, A. G., and R. R. Rueckert. 1993. WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present. J. Virol. 67:1246-1254.
33. Muckelbauer, J. K., M. Kremer, I. Minor, L. Tong, A. Zlotnick, J. E. Johnson, and M. G. Rossmann. 1995. Structure determination of coxsackievirus B3 to 3.5 Å resolution. Acta Crystallogr. Sect. D 51:871-887.
34. Oliveira, M. A., R. Zhao, W. Lee, M. J. Kremer, I. Minor, R. R. Rueckert, G. D. Diana, D. C. Pevear, F. J. Dutko, M. A. McKinlay, and M. G. Rossmann. 1993. The structure of human rhinovirus 16. Structure 1:51-68.
35. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326.
36. i by beef heart mitochondrial adenosine triphosphatase. J. Biol. Chem. 252:2891-2899.
37. Pevear, D. C. 1999. Activity of pleconaril against enteroviruses. Adv. Exp. Med. Biol. 458:69-76.
38. Pevear, D. C., M. J. Fancher, P. J. Felock, M. G. Rossmann, M. S. Miller, G. Diana, A. M. Treasurywala, M. A. McKinlay, and F. J. Dutko. 1989. Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J. Virol. 63:2002-2007.
39. Rodgers, D. W. 2001. Cryocrystallography techniques and devices, p. 202-208. In M. G. Rossmann and E. Arnold (ed.), International tables for crystallography. Vol. F, crystallography of biological macromolecules. Kluwer Academic Publishers, Dordrecht, The Netherlands.
40. Rogers, J. M., G. D. Diana, and M. A. McKinlay. 1999. Pleconaril. A broad spectrum antipicornaviral agent, p. 69-75. In S. Mills, P. A. Volberding, and L. Corey (ed.), Antiviral chemotherapy 5. New directions for clinical applications and research. Kluwer Academic/Plenum Publishers, New York, N.Y.
41. Rossmann, M. G. 1994. Viral cell recognition and entry. Protein Sci. 3:1712-1725.
42. Rossmann, M. G., E. Arnold, J. W. Erickson, E. A. Frankenberger, J. P. Griffith, H. J. Hecht, J. E. Johnson, G. Kamer, M. Luo, A. G. Mosser, R. R. Rueckert, B. Sherry, and G. Vriend. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (London) 317:145-153.
43. Rossmann, M. G., Y. He, and R. J. Kuhn. 2002. Picornavirus-receptor interactions. Trends Microbiol. 10:324-331.
44. Rossmann, M. G., R. McKenna, L. Tong, D. Xia, J. Dai, H. Wu, H. K. Choi, and R. E. Lynch. 1992. Molecular replacement real-space averaging. J. Appl. Crystallogr. 25:166-180.
45. Rueckert, R. R. 1996. Picornaviridae: the viruses and their replication, p. 609-654. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
46. Shepard, D. A., B. A. Heinz, and R. R. Rueckert. 1993. WIN compounds inhibit both attachment and eclipse of human rhinovirus 14. J. Virol. 67: 2245-2254.
47. Smith, T. J., E. S. Chase, T. J. Schmidt, N. H. Olson, and T. S. Baker. 1996. Neutralizing antibody to human rhinovirus 14 penetrates the receptor-binding canyon. Nature (London) 383:350-354.
48. Smith, T. J., M. J. Kremer, M. Luo, G. Vriend, E. Arnold, G. Kamer, M. G. Rossmann, M. A. McKinlay, G. D. Diana, and M. J. Otto. 1986. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286-1293.
49. Verdaguer, N., D. Blaas, and I. Fita. 2000. Structure of human rhinovirus serotype 2 (HRV2). J. Mol. Biol. 300:1181-1196.
50. Zhao, R., D. C. Pevear, M. J. Kremer, V. L. Giranda, J. A. Kofron, R. J. Kuhn, and M. G. Rossmann. 1996. Human rhinovirus 3 at 3.0 Å resolution. Structure 4:1205-1220.